{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013400/OMIM:613743","label":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","mondoId":"MONDO:0013400","onsetQualifier":null,"recordKeys":["1d71d7b2583bdb4f6b9efe1639feb8521c9d6f9252fd4656b3823f60b0d4dba4","65667752f738a1f61adf464e08540f80c2674bae4631eb83b40b9b540873cf5c","6acbb080c57e28636e637506411184c1cb7fb3d2b3e0ca332120dfabdbf2fa3b","9580ddc96a9e3a2adbb0ae5c7892d55d81fe13379359089db015731d7ce26831","b7ef3c13428228f8f5f9bd13069545e970517dcf21eebf722d41cf08350b0fbb","d54a9a8c88102909390ab5c4c1c5966ddedf2cc2aa040b948def5b9da1395cb8"],"recordQualifiers":{},"scopeLabel":"OMIM:613743","sourceIds":["OMIM:613743"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0013400/ORPHA:168558","label":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","mondoId":"MONDO:0013400","onsetQualifier":null,"recordKeys":["0bdce8b76cdfc96e32d2bac8fcd8ffa63f4d13d81e8cb73fe0a945725df9fa2c","14acb9aba5ffd8c8ea6c2cfd2eede3e3b00935ed0cf58de0fed6a85ead578114","14ec8d993e0632714b07a71e8cf1ce092cf784705edaa25a8ed79794bc382c69","2d5be626df7c2ed68c2785925a05fb97d3e3f6e04f7e91ef10ee61bce4462f02","327f2bbc42675c3e4c033860c02bd1ccb2274533e3065cbf60b8c8e72e8bd639","3b24c21a0cfed393163487fa313927bff433ec650c91471600e4589c4403dd2b","3b67bdd5346ca1ee5e0d9c830ad9f09de8fb681d65ecb148a16a746f58beba1a","3fae8fe0d093df66bcb0bbc25569b30a2ca5f62f734e75c7131a3c2aba434534","3fdb5e6d55dad5a9b5e2afad8426d69fe96f6c677bcea7113fa5b9a5d4ccba4b","42e7085f839d9e00a0f76054640e082848b7595be8a73e2e35d081c52a50c1d2","448f02916802696cf97fcbe0e3a39346804777ff4d8bae704fc5ff3c48edb12e","45435afad900f8bbe801e4fa8b57d9f8ac56153615ac917cc283a3699500f742","4f009fd0b7f4770024e02ebc49c9cf1aeac4b5db0ecf03a6de07f211a34a4dda","5460f6e105eef7b86fcbc68180b7aaa9c07f60521538afe6264cd5bd5379d4d1","573ca6dc0b8dfb23552395cad9305ae511e63e1f7fae40254e10ae8ec3e7c125","626e291e54567f6a5b4d48057caa57558f118e4a5af54e04362a82010d54555e","6373ccefcb64a087a39498ce5ae8705a47237f05bfde5ad7d08cb27db01e46c7","696ae312b778549712a9a7cc62d1d3ef3f690f5c82bfc7f6279b481bcd0b7c96","72108876b5fbc4e80e9b297ba35bc24a9627ab83098b5a71d97c2a228d375ae1","75e583dc2489da7cf547d08cfda21405767c8f7edae2bccf5bfabec5eea9d8c3","868b662f0881ae4b8550e34825d24a015c775f739f83d3eae0921672e59b0b20","869d9e6ab14444744f598a68045a22e656686c41e03f6bdc7687a99976ec7504","8d156713142e6ed726be72a03c58a939e7f7b4bcb243894a96ac9a5334a2c6e1","94e63a38a8c4a10af49a84f4f05b86b55c0584455a96d3a5f9cdca499b592fb5","983ef6bc4308514051e0c49a2bf4d8894f039334f85bee92264ba675cbc2342e","9da13c93f6e25b057494e1b05be19c3148dff82483e1ea7cfa6a2dc7f28431c0","a129f403d636b8fd2343fac88ff4955cc0e9180b11b8edba039bb9ed744faa90","aaa7b64fd42ba3afe278c569c45a65b3095a608ccd7575eb969d9249388f68ec","b6c56fdd3c5a096f98efe97ea0885a0ddf88998b1c0ff37718ce322fc265a0cd","ba82fec032bb6acf361b299e549c7e1d9c701a8cffa06ee4a2d32ddc27e45339","c0b1e2b40d641ed33cd935ece0716159add0ee5272faa6a7022e00c53b227b4d","c1d8ade1c6565977e22228ae155b14737058f276f09da7b7cd88e33e80ef0545","c26b419ec9604dcbff2c5c3428eee5e3bfc23d4dae576701c0d7d4269ae0cd4d","c74d63ef5ac2b4728762775ab725ce910409b7d9cb2142ab5b513a88de58add0","c90f3b7b388bb8a96d53752cbc0c03000d6f495bd62c5aa539435e9166c712f7","c96bd23049230ba289922c28155944d6af13d02cb2a8091e1c666ff97e6ef6ff","cc22adf2bc10c0159c79fe9b5d0375adbd6345d499ab5aecbe63eb55e90384ee","ceb71b1bfe339b9738e2f5b287b9fbff649d2b0c55ff3c2ee2cc86d5e2f48a15","d288dd4a56f11eb9d4564782399e0f53a73098b942d5c3b66bd6bbd173e37a53","dcf0d0b11afc50a5a77bbe7e724e90db5bf72d87993d3824a11db30419133ba8","ded19c38674bdc8b8bf3181e329eb099b5d7c6fda120b27bab30ee12f1239d52","e430d50fe98018e1362bc891c8c85763914d8a8326d24e195200e9a50bfca0b5","e6d21b6ca01e597e7774355d92b428d590e08f92d1b3fada18c277ab58f6274d","e7e06904ba0a9ae73c9ad61842278ce548d06e17e68bd7a2336591ea697a9c24","edcb0f629cb33e64c6d50cf0fbe04320cd448a3ce84d4c475f00d3157df81f71","efac91f8859bbe13b9c7d9723b3d1db82b06b99ae67d5086fc5df98f9d35d4a2","f5a160f94a47d4c2c4a39de9e12edeaa941f42cb511a1021889db4f8314369a5","f64ef2a7480694884b0517134c1bd388cf79100ee2df448570f0fcbcbfbc0862","f932dbcb7d48703ba026ca282c68c7a28dd6d42dbfd21ce1943530b9cf575e37","fb392f706d919e1bcd6576d4ffa9d92938a310a4601cc2d9a8f8ffc6c3578328"],"recordQualifiers":{},"scopeLabel":"ORPHA:168558","sourceIds":["ORPHA:168558"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013400/OMIM:613743","MONDO:0013400/ORPHA:168558"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":56,"sourceGroups":{"omim":6,"orphanet":50,"published":0}},"features":[{"hpoId":"HP:0003107","label":"Abnormal circulating cholesterol concentration","primary":false},{"hpoId":"HP:0012244","label":"Abnormal sex determination","primary":false},{"hpoId":"HP:0012598","label":"Abnormal urine potassium concentration","primary":false},{"hpoId":"HP:0000142","label":"Abnormal vagina morphology","primary":false},{"hpoId":"HP:0001197","label":"Abnormality of prenatal development or birth","primary":false},{"hpoId":"HP:0010789","label":"Abnormality of the Leydig cells","primary":false},{"hpoId":"HP:0008187","label":"Absence of secondary sex characteristics","primary":false},{"hpoId":"HP:0001941","label":"Acidosis","primary":false},{"hpoId":"HP:0000835","label":"Adrenal hypoplasia","primary":false},{"hpoId":"HP:0000846","label":"Adrenal insufficiency","primary":false},{"hpoId":"HP:0011749","label":"Adrenocorticotropic hormone excess","primary":false},{"hpoId":"HP:0001274","label":"Agenesis of corpus callosum","primary":false},{"hpoId":"HP:0000033","label":"Ambiguous genitalia, male","primary":false},{"hpoId":"HP:0000151","label":"Aplasia of the uterus","primary":false},{"hpoId":"HP:0008665","label":"Clitoral hypertrophy","primary":false},{"hpoId":"HP:0000028","label":"Cryptorchidism","primary":false},{"hpoId":"HP:0004319","label":"Decreased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0030349","label":"Decreased circulating androgen concentration","primary":false},{"hpoId":"HP:0008163","label":"Decreased circulating cortisol level","primary":false},{"hpoId":"HP:0000144","label":"Decreased fertility","primary":false},{"hpoId":"HP:0008734","label":"Decreased testicular size","primary":false},{"hpoId":"HP:0001944","label":"Dehydration","primary":false},{"hpoId":"HP:0000823","label":"Delayed puberty","primary":false},{"hpoId":"HP:0002750","label":"Delayed skeletal maturation","primary":false},{"hpoId":"HP:0008232","label":"Elevated circulating follicle stimulating hormone level","primary":false},{"hpoId":"HP:0011969","label":"Elevated circulating luteinizing hormone level","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0008730","label":"Female external genitalia in individual with 46,XY karyotype","primary":false},{"hpoId":"HP:0007574","label":"Generalized bronze hyperpigmentation","primary":false},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":false},{"hpoId":"HP:0000771","label":"Gynecomastia","primary":false},{"hpoId":"HP:0002153","label":"Hyperkalemia","primary":false},{"hpoId":"HP:0012605","label":"Hypernatriuria","primary":false},{"hpoId":"HP:0000953","label":"Hyperpigmentation of the skin","primary":false},{"hpoId":"HP:0002902","label":"Hyponatremia","primary":false},{"hpoId":"HP:0002615","label":"Hypotension","primary":false},{"hpoId":"HP:0011106","label":"Hypovolemia","primary":false},{"hpoId":"HP:0003154","label":"Increased circulating ACTH level","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0000848","label":"Increased circulating renin concentration","primary":false},{"hpoId":"HP:0030369","label":"Induced vaginal delivery","primary":false},{"hpoId":"HP:0000037","label":"Male pseudohermaphroditism","primary":false},{"hpoId":"HP:0012854","label":"Midshaft hypospadias","primary":false},{"hpoId":"HP:0001998","label":"Neonatal hypoglycemia","primary":false},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0001622","label":"Premature birth","primary":false},{"hpoId":"HP:0008207","label":"Primary adrenal insufficiency","primary":false},{"hpoId":"HP:0004349","label":"Reduced bone mineral density","primary":false},{"hpoId":"HP:0000127","label":"Renal salt wasting","primary":false},{"hpoId":"HP:0012245","label":"Sex reversal","primary":false},{"hpoId":"HP:0100779","label":"Urogenital sinus anomaly","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013400","records":[{"frequencyKind":"range","key":"0bdce8b76cdfc96e32d2bac8fcd8ffa63f4d13d81e8cb73fe0a945725df9fa2c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012244","is_excluded":false,"label":"Abnormal sex determination","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14acb9aba5ffd8c8ea6c2cfd2eede3e3b00935ed0cf58de0fed6a85ead578114","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011106","is_excluded":false,"label":"Hypovolemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14ec8d993e0632714b07a71e8cf1ce092cf784705edaa25a8ed79794bc382c69","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000151","is_excluded":false,"label":"Aplasia of the uterus","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1d71d7b2583bdb4f6b9efe1639feb8521c9d6f9252fd4656b3823f60b0d4dba4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011749","is_excluded":false,"label":"Adrenocorticotropic hormone excess","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2d5be626df7c2ed68c2785925a05fb97d3e3f6e04f7e91ef10ee61bce4462f02","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012245","is_excluded":false,"label":"Sex reversal","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"327f2bbc42675c3e4c033860c02bd1ccb2274533e3065cbf60b8c8e72e8bd639","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001998","is_excluded":false,"label":"Neonatal hypoglycemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b24c21a0cfed393163487fa313927bff433ec650c91471600e4589c4403dd2b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011969","is_excluded":false,"label":"Elevated circulating luteinizing hormone level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b67bdd5346ca1ee5e0d9c830ad9f09de8fb681d65ecb148a16a746f58beba1a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002750","is_excluded":false,"label":"Delayed skeletal maturation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fae8fe0d093df66bcb0bbc25569b30a2ca5f62f734e75c7131a3c2aba434534","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008187","is_excluded":false,"label":"Absence of secondary sex characteristics","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fdb5e6d55dad5a9b5e2afad8426d69fe96f6c677bcea7113fa5b9a5d4ccba4b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012598","is_excluded":false,"label":"Abnormal urine potassium concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"42e7085f839d9e00a0f76054640e082848b7595be8a73e2e35d081c52a50c1d2","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"448f02916802696cf97fcbe0e3a39346804777ff4d8bae704fc5ff3c48edb12e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012854","is_excluded":false,"label":"Midshaft hypospadias","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"45435afad900f8bbe801e4fa8b57d9f8ac56153615ac917cc283a3699500f742","raw":{"aspect":"P","body_system":"breast","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000771","is_excluded":false,"label":"Gynecomastia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4f009fd0b7f4770024e02ebc49c9cf1aeac4b5db0ecf03a6de07f211a34a4dda","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5460f6e105eef7b86fcbc68180b7aaa9c07f60521538afe6264cd5bd5379d4d1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001941","is_excluded":false,"label":"Acidosis","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"573ca6dc0b8dfb23552395cad9305ae511e63e1f7fae40254e10ae8ec3e7c125","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000144","is_excluded":false,"label":"Decreased fertility","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"626e291e54567f6a5b4d48057caa57558f118e4a5af54e04362a82010d54555e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002902","is_excluded":false,"label":"Hyponatremia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6373ccefcb64a087a39498ce5ae8705a47237f05bfde5ad7d08cb27db01e46c7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"65667752f738a1f61adf464e08540f80c2674bae4631eb83b40b9b540873cf5c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012245","is_excluded":false,"label":"Sex reversal","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"696ae312b778549712a9a7cc62d1d3ef3f690f5c82bfc7f6279b481bcd0b7c96","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008163","is_excluded":false,"label":"Decreased circulating cortisol level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6acbb080c57e28636e637506411184c1cb7fb3d2b3e0ca332120dfabdbf2fa3b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"72108876b5fbc4e80e9b297ba35bc24a9627ab83098b5a71d97c2a228d375ae1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000028","is_excluded":false,"label":"Cryptorchidism","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"75e583dc2489da7cf547d08cfda21405767c8f7edae2bccf5bfabec5eea9d8c3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000142","is_excluded":false,"label":"Abnormal vagina morphology","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"868b662f0881ae4b8550e34825d24a015c775f739f83d3eae0921672e59b0b20","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004349","is_excluded":false,"label":"Reduced bone mineral density","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"869d9e6ab14444744f598a68045a22e656686c41e03f6bdc7687a99976ec7504","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030369","is_excluded":false,"label":"Induced vaginal delivery","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8d156713142e6ed726be72a03c58a939e7f7b4bcb243894a96ac9a5334a2c6e1","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001197","is_excluded":false,"label":"Abnormality of prenatal development or birth","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94e63a38a8c4a10af49a84f4f05b86b55c0584455a96d3a5f9cdca499b592fb5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007574","is_excluded":false,"label":"Generalized bronze hyperpigmentation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9580ddc96a9e3a2adbb0ae5c7892d55d81fe13379359089db015731d7ce26831","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000953","is_excluded":false,"label":"Hyperpigmentation of the skin","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"983ef6bc4308514051e0c49a2bf4d8894f039334f85bee92264ba675cbc2342e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9da13c93f6e25b057494e1b05be19c3148dff82483e1ea7cfa6a2dc7f28431c0","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002615","is_excluded":false,"label":"Hypotension","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a129f403d636b8fd2343fac88ff4955cc0e9180b11b8edba039bb9ed744faa90","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002153","is_excluded":false,"label":"Hyperkalemia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aaa7b64fd42ba3afe278c569c45a65b3095a608ccd7575eb969d9249388f68ec","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000835","is_excluded":false,"label":"Adrenal hypoplasia","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b6c56fdd3c5a096f98efe97ea0885a0ddf88998b1c0ff37718ce322fc265a0cd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b7ef3c13428228f8f5f9bd13069545e970517dcf21eebf722d41cf08350b0fbb","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000846","is_excluded":false,"label":"Adrenal insufficiency","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ba82fec032bb6acf361b299e549c7e1d9c701a8cffa06ee4a2d32ddc27e45339","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008232","is_excluded":false,"label":"Elevated circulating follicle stimulating hormone level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0b1e2b40d641ed33cd935ece0716159add0ee5272faa6a7022e00c53b227b4d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000127","is_excluded":false,"label":"Renal salt wasting","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c1d8ade1c6565977e22228ae155b14737058f276f09da7b7cd88e33e80ef0545","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000848","is_excluded":false,"label":"Increased circulating renin concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c26b419ec9604dcbff2c5c3428eee5e3bfc23d4dae576701c0d7d4269ae0cd4d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011749","is_excluded":false,"label":"Adrenocorticotropic hormone excess","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c74d63ef5ac2b4728762775ab725ce910409b7d9cb2142ab5b513a88de58add0","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008730","is_excluded":false,"label":"Female external genitalia in individual with 46,XY karyotype","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c90f3b7b388bb8a96d53752cbc0c03000d6f495bd62c5aa539435e9166c712f7","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001622","is_excluded":false,"label":"Premature birth","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c96bd23049230ba289922c28155944d6af13d02cb2a8091e1c666ff97e6ef6ff","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc22adf2bc10c0159c79fe9b5d0375adbd6345d499ab5aecbe63eb55e90384ee","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008734","is_excluded":false,"label":"Decreased testicular size","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ceb71b1bfe339b9738e2f5b287b9fbff649d2b0c55ff3c2ee2cc86d5e2f48a15","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000033","is_excluded":false,"label":"Ambiguous genitalia, male","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d288dd4a56f11eb9d4564782399e0f53a73098b942d5c3b66bd6bbd173e37a53","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003154","is_excluded":false,"label":"Increased circulating ACTH level","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d54a9a8c88102909390ab5c4c1c5966ddedf2cc2aa040b948def5b9da1395cb8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613743","disease_name":"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000127","is_excluded":false,"label":"Renal salt wasting","onset_id":null,"reference":"OMIM:613743","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"dcf0d0b11afc50a5a77bbe7e724e90db5bf72d87993d3824a11db30419133ba8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ded19c38674bdc8b8bf3181e329eb099b5d7c6fda120b27bab30ee12f1239d52","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030349","is_excluded":false,"label":"Decreased circulating androgen concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e430d50fe98018e1362bc891c8c85763914d8a8326d24e195200e9a50bfca0b5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008665","is_excluded":false,"label":"Clitoral hypertrophy","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6d21b6ca01e597e7774355d92b428d590e08f92d1b3fada18c277ab58f6274d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004319","is_excluded":false,"label":"Decreased circulating aldosterone concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e7e06904ba0a9ae73c9ad61842278ce548d06e17e68bd7a2336591ea697a9c24","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012605","is_excluded":false,"label":"Hypernatriuria","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edcb0f629cb33e64c6d50cf0fbe04320cd448a3ce84d4c475f00d3157df81f71","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003107","is_excluded":false,"label":"Abnormal circulating cholesterol concentration","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"efac91f8859bbe13b9c7d9723b3d1db82b06b99ae67d5086fc5df98f9d35d4a2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008207","is_excluded":false,"label":"Primary adrenal insufficiency","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f5a160f94a47d4c2c4a39de9e12edeaa941f42cb511a1021889db4f8314369a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001274","is_excluded":false,"label":"Agenesis of corpus callosum","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f64ef2a7480694884b0517134c1bd388cf79100ee2df448570f0fcbcbfbc0862","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100779","is_excluded":false,"label":"Urogenital sinus anomaly","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f932dbcb7d48703ba026ca282c68c7a28dd6d42dbfd21ce1943530b9cf575e37","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010789","is_excluded":false,"label":"Abnormality of the Leydig cells","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb392f706d919e1bcd6576d4ffa9d92938a310a4601cc2d9a8f8ffc6c3578328","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:168558","disease_name":"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000037","is_excluded":false,"label":"Male pseudohermaphroditism","onset_id":null,"reference":"ORPHA:168558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"congenital-adrenal-insufficiency-with-46-xy-sex-reversal-or-46-xy-disorder-of-sex-development-adrenal-insufficiency-due-to-cyp11a1-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency"},"schemaVersion":1}